Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Using whole blood for trauma patients with severe bleeding

Official title: Whole Blood vs. Blood Components Therapy in the Hemostatic Resuscitation of Severe Trauma Patients: An Open-label, Randomized, Controlled Clinical Trial

Run by Fundacion Clinica Valle del Lili · NCT05634109 · Data updated 2026-11-12

This study tests whether using whole blood for trauma patients with severe bleeding can help them survive better and have fewer organ problems compared to traditional blood treatments.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment220 (estimated)
SponsorFundacion Clinica Valle del Lili
Academic / other
Locations1 site (Cali, Valle del Cauca Department)
StatusRecruiting
StartedJanuary 14, 2023
Main results expectedDecember 2025
Study endsMarch 2026
Registry record updatedFebruary 27, 2025
Trial IDNCT05634109 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who have experienced severe trauma and are in need of a massive blood transfusion.

Probably not a fit

Patients who have sustained devastating injuries or have specific contraindications, such as severe traumatic brain injury or burns over 20%, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the clinical impact of hemostatic resuscitation using whole blood compared to traditional blood component therapy in trauma patients experiencing hemorrhagic shock. It aims to determine the effects on mortality rates and organ dysfunction over a 28-day period. The trial will be conducted as an open-label, randomized, prospective, single-center study, enrolling adult patients who require a blood transfusion due to severe trauma. The research seeks to clarify the benefits of whole blood transfusion in emergency settings, particularly in low-resource environments.

Why it matters

Potential benefit: If successful, this approach could significantly reduce mortality and improve recovery outcomes for trauma patients with severe bleeding.

How similar studies have gone: While the use of whole blood in trauma settings is gaining attention, this specific approach is still being evaluated and has not been widely tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (\> 18 years)
* Activating institutional trauma code for trauma patients with hemorrhagic shock.
* Candidate for massive transfusion (Patient with an Assessment Blood Consumption (ABC) Score ≥ 2 or at the discretion of the treating physician)
* Concurrent availability of whole blood or blood component therapy

Exclusion Criteria:

* More than 4 hours from trauma to hospital admission
* More than 2 hours from hospital admission to randomization
* Transfusion of more than one packed red blood cell unit prior to randomization.
* Patients who have undergone surgery (laparotomy, thoracotomy, or sternotomy) before hospital admission.
* In-extremis patients with devastating injuries (expected to die within 60 minutes).
* Blood group other than to O or A and positive Rh factor
* Severe traumatic brain injury in which neurosurgical intervention is futile (partial decapitation, massive intracranial hemorrhage, or transcranial gunshot wounds).
* Burns over 20% of the total body surface area.
* Suspected airway burn.
* Cardiopulmonary resuscitation (CPR) before arrival at the ED.
* CPR for more than 5 minutes before randomization.
* Do not resuscitate order.
* Incarcerated/prisoners.
* Known pregnancy in the ED.
* Patient or legal representative who refuse to participate in clinical research studies.

Where it's running

  • Fundacion Clinica Valle del Lili
    Cali, Valle del Cauca Department, Colombia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.